Code
|
3027E
|
MA number
|
44/0062/23-S
|
Product Form:
|
sol inj 1x1,4 ml/3,5 mg (liek.inj.skl.)
|
MA Status:
|
R - Valid Marketing Authorisation
|
Type of procedure:
|
Mutual recognition procedure
|
MAH, country:
|
EVER Valinject GmbH, Austria
|
Therapeutic Class:
|
44 - CYTOSTATICA
|
ATC:
|
L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
L01 |
ANTINEOPLASTIC AGENTS |
L01X |
OTHER ANTINEOPLASTIC AGENTS |
L01XG |
Proteasome inhibitors |
L01XG01 |
Bortezomib |
|
Shelf life:
|
24 |
Container:
|
glass vial
|
Route of admin.:
|
Subcutaneous and intravenous use
|